Cardiovascular complications in patients with pheochromocytoma: A mini-review

Biomedicine and Pharmacotherapy

Volumn 64, Issue 7, 2010, Pages 505-509

  Galetta, Fabio ^a   Franzoni, Ferdinando ^a   Bernini, Giampaolo ^a   Poupak, Fallawi ^a   Carpi, Angelo ^b   Cini, Giuseppe ^a   Tocchini, Leonardo ^a   Antonelli, Alessandro ^a   Santoro, Gino ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Cardiovascular complications; Pheochromocytoma; Ultrasonic tissue characterization

Indexed keywords

ADRENALIN; CATECHOLAMINE; COLLAGEN; NORADRENALIN;

ACUTE HEART INFARCTION; ANXIETY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; HEADACHE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; LUNG EDEMA; METABOLIC DISORDER; NERVE ENDING; NONHUMAN; PALLOR; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; SHOCK; SYMPATHETIC NERVE; TACHYCARDIA; ULTRASOUND; VASCULAR FIBROSIS; VIDEODENSITOMETRY;

ADRENAL GLAND NEOPLASMS; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; HUMANS; PHEOCHROMOCYTOMA; ULTRASONOGRAPHY; VASCULAR DISEASES;

EID: 77956428898     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.09.014     Document Type: Review

References (72)

1. Cryer P.E. Diseases of the sympathochromaffin system. Endocrinology and metabolism 2001, 525-551. McGraw-Hill, New York (NY). 4th ed. P. Felig, L.A. Frohman (Eds.).
2. Zelinda T., Strauch B., Petrak O., Holaj R., Vrankova A., Weisserova H., et al. Widimsky Jr J. Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients. J Hypertens 2005, 23:2033-2039.
3. Stein P.P., Black H. A simplified diagnostic approach to pheochromocytoma. Medicine 1990, 70:46-66.
4. Lenders J.W., Eisenhofer G., Mannelli M., Pacak K. Phaeochromocytoma. Lancet 2005, 366:665-675.
5. Denolle T., Chatellier G., Julien J, Battaglia C., Luo P., Plouin P.F. Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. Am J Hypertens 1993, 6:907-913.
6. Schlaich M.P., Kaye D.M., Lambert E., Sommerville M., Socratous F. Esler MD Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003, 108:560-565.
7. Kelm M., Schafer S., Mingers S., Heydthausen M., Vogt M., Motz W., et al. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 1996, 14:1357-1364.
8. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1-adrenergic response. J Clin Invest 1983, 72:732-738.
9. Fouad-Tarazi F.M., Imamura M., Bravo E.L., Rossi G., Nagi H.K., Lin W.W., et al. Differences in left ventricular structural and functional changes between pheochromocytoma and essential hypertension. Role of elevated circulating catecholamines. Am J Hypertens 1992, 5:134-140.
10. Shub C., Cueto-Garcia L., Sheps S.G., lstrup D.M., Tajik A.J. Echocardiographic findings in pheochromocytoma. Am J Cardiol 1986, 57:971-975.
11. Attar M.N., Moulik P.K., Salem G.D., Rose E.L., Khaleeli A.A. Phaechromocytoma presenting as dilated cardiomyopathy. Int J Clin Pract 2003, 57:547-548.
12. Gupta M.K., Neelakantan T.V., Sanghamitra M., Tyagi R.K., Dinda A., Maulik S., et al. An assessment of the role of reactive oxygen species and redox signaling in norepinephrine-induced apoptosis and hypertrophy of H9c2 cardiac myoblasts. Antioxidants and Redox Signaling 2006, 8:1081-1093.
13. Radtke W.E., Kazmier F.J., Rutherford B.D., et al. Cardiovascular complications of pheochromocytoma crisis. Am J Cardiol 1975, 35:701-705.
14. Fu Z., Feng Y., Xu H., Zhang X., Shi C., Gu X. Role of norepinephrine in development of short-term myocardial hibernation. Acta Pahrmacologica Sinica 2006, 27:158-164.
15. Carlos R., Jessurun M.D., Karolina J. Pheochromocytoma-induced myocardial infarction in pregnancy. Tex Heart Inst J 1993, 20:120-122.
16. Yamanaka O., Yasumasa F., Nakamura T. Myocardial stunning" -like phenomenon during a crisis of phechromocytoma. Jpn Circ J 1994, 58:737-742.
17. Takizawa M., Kobayakawa N., Uozumi H., et al. a case of transient left ventricular ballooing with pheochromocytoma, supporting pathogenetis role of catecholamines in stress-induced cardiomyopathy or Takotsubo cardiomyopathy. Int J Cardiol 2007, 114:e15-e17.
18. Lassnig E., Weber T., Auer J., Nomeyer R., Eber B. Pheochromocytoma crisis presenting with shock and tako-tsubo-like cardiomyopathy. Int J Cardiol 2009, 134:e138-140.
19. van Iperen C.E., Giezen J., Kramer W.L.M., Lips C.J.M., Bartelink A.K.M. Acute dyspnea resulting from pulmonary oedema as the first sign of a pheochromocytoma. Respiration 2001, 68:323-326.
20. Takeshita T., Shima H., Oishi S., Machida N. Uchiyama K. noncardiogenic pulmonary edema as the first manifestation of pheochromocytoma: a case report. Radiat Med 2005, 23:133-138.
21. Bergland B.E. Pheochromocytoma presenting as shock. Am J Emerg Med 1989, 7:44-48.
22. Olson S.W., Deal L.E., Piesman M. Epinephrine-secreting pheochromocytoma presenting with cardiogenic shock and profound hypocalcemia. An Intern Med 2004, 140:849-851.
23. Goldbaum T.S., Nenochowicz S., Mustafa M., et al. Pheochromocytoma presenting with Prinzmetal's angina. Am J Med 1986, 81:921-922.
24. Cheng T.O., Bashour T.T. Strinking electrocardiographic changes associated with pheochromocytoma masquerading as ischemic heart disease. Chest 1976, 70:397-399.
25. Shimizu K., Miura Y., Megfuro Y., et al. QT prolongation with torsade de pointes in pheochromocytoma. Am Heart J 1992, 124:235-239.
26. McManus B.M., Fleury T.A., Roberts W.C. Fatal catecholamine crisis in pheochromocytoma: Curable cause of cardiac arrest. Am Heart J 1981, 102:930-932.
27. Zierhut W., Zimmer H.G. Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 1989, 65:1417-1425.
28. Simpson P., McGrath A., Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982, 51:787-801.
29. Zhang H., Faber J.E. Trophic effect of norepinephrine on arterial intima-media and adventitia is augmented by injury and mediated by different α1-adrenoceptor subtypes. Circ Res 2001, 89:815-822.
30. Faber J.E., Yang N., Xin X. Expression of α-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture. J Pharmacol Exp Ther 2001, 298:441-452.
31. Xin X., Yang N., Eckhart A.D., Faber J.E. α1D-adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol Pharmacol 1997, 51:764-775.
32. Zhang H., Facemire C.S., Banes A.J., Faber J.E. Different α-adrenoceptors mediate migration of vascular smooth muscle cells and adventitial fibroblasts in vitro. Am J Physiol Heart Circ Physiol 2002, 282:H2364-H2370.
33. Head R.J. Hyperadrenergic innervation and vascular smooth muscle hyperplastic change. Blood Vessels 1991, 28:173-178.
34. Dao H.H., Lemay J., de Champlain J., deBlois D., Moreau P. Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent. J Hypertens 2001, 19:1965-1973.
35. Johnson M.D., Grignolo A., Kuhn C.M., Schanberg S.M. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats. Life Sci 1983, 33:169-180.
36. Nakaki T., Nakayama M., Yamamoto S., Kato R. α1-Adrenergic stimulation and ß2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 1990, 37:30-36.
37. deBlois D., Schwartz S.M., van Kleef E.M., Su J.E., Griffin K.A., Bidani A.K., et al. Chronic α1-adrenoreceptor stimulation increases DNA synthesis in rat arterial wall. Modulation of responsiveness after vascular injury. Arterioscler Thromb Vasc Biol 1996, 16:1122-1129.
38. Docherty J.R. Subtypes of functional α1- and α2-adrenoceptors. Eur J Pharmacol 1998, 361:1-15.
39. Erami C., Zhang H., Ho J.G., French D.M., Faber J.E. α(1)-Adrenoceptor stimulation directly induces growth of vascular wall in vivo. Am J Physiol Heart Circ Physiol 2002, 283:H1577-H1587.
40. Varma D.R., Deng X.F. Cardiovascular α1-adrenoceptor subtypes: functions and signaling. Can J Physiol Pharmacol 2000, 78:267-292.
41. Teeters J.C., Erami C., Zhang H., Faber J.E. Systemic, α1A-adrenoceptor antagonist inhibits neointimal growth after balloon injury of rat carotid artery. Am J Physiol Heart Circ Physiol 2003, 284:H385-H392.
42. Zhang H., Cotecchia S., Thomas S.A., Tanoue A., Tsujimoto G., Faber J.E. Gene deletion of dopamine ß-hydroxylase and α1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling. Am J Physiol Heart Circ Physiol 2004, 287:H2106-H2114.
43. Vecchione C., Fratta L., Rizzoni D., Notte A., Poulet R., Porteri E., et al. Cardiovascular influences of α1b-adrenergic receptor defect in mice. Circulation 2002, 105:1700-1707.
44. O'Callaghan C.J., Williams B. The regulation of human vascular smooth muscle extracellular matrix protein production by α- and ß-adrenoceptor stimulation. J Hypertens 2002, 20:287-294.
45. Schiffrin E.L. Vascular smooth muscle growth and extracellular matrix deposition: is there a role for the sympathetic nervous system?. J Hypertens 2002, 20:179-181.
46. Chen L., Xin X., Eckhart A.D., Yang N., Faber J.E. Regulation of vascular smooth muscle growth by α1-adrenoreceptor subtypes in vitro and in situ. J Biol Chem 1995, 270:30980-30988.
47. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an α1 adrenergic response. J Clin Invest 1983, 72:732-738.
48. Erami C., Zhang H., Tanoue A., Tsujimoto G., Thomas S.A. Faber JE Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling. Am J Physiol Heart Circ Physiol 2005, 289:H744-H753.
49. Gaballa M.A., Jacob C.T., Raya T.E., Liu J., Simon B., Goldman S. Large artery remodeling during aging: biaxial passive and active stiffness. Hypertension 1998, 32:437-443.
50. Higashi Y., sasaki S., Nakagawa K., kimura M., Sasaki S., Noma K., et al. Excess norepinephrine impairs both endothelium-dependent and -independent vasodilation in patients with pheochromocytoma. Hypertension 2002, 39:513-518.
51. Lerman A., Zeiher A.M. Endothelial function: cardiac events. Circulation 2005, 1111:363-368.
52. Holaj R., Zelinka T., Wichterle D., Petrak O., Strauch B., Vrankova A., et al. Increased carotid intima-media thickness in patients with pheochromocytoma in comparison to essential hypertension. J Hum Hypertens 2009, 23:350-358.
53. Pauletto P., Scannapieco G., Pessina A.C. Sympathetic drive and vascular damage in hypertension and atherosclerosis. Hypertension 1991, 17(Suppl. 4):III75-III81.
54. Dinenno F.A., Jones P.P., Seals D.R., Tanaka H. Age-associated arterial wall thickening is related to elevations in sympathetic activity in healthy humans. Am J Physiol Heart Circ Physiol 2000, 278:H1205-H1210.
55. Rizzoni D., Muiesan M.L., Porteri E., Salvetti M., Castellano M., Bettoni G., et al. Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol 1998, 32:985-992.
56. Rizzoni D., Porteri E., Castellano M., Bettoni G., Muiesan M.L., Muiesan P., et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996, 28:785-790.
57. Porteri E., Rizzoni D., Mulvany M.J., De Ciuceis C., Sleiman I., Boari G.E., et al. Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans. J Hypertens 2003, 21:2345-2352.
58. Hall C.S., Scott M.J., Lanza G.M., Miller J.G., Wickline S.A. The extracellular matrix is an important source of ultrasound backscatter from myocardium. J Acoust Soc Am 2000, 107:612-619.
59. Miller J.G., Perez J.E., Sobel B.E. Ultrasonic characterization of myocardium. Prog Cardiovasc Dis 1985, 28:85-110.
60. Perez J.E., Barzilai B., Madaras E.I., Glueck R.M., Saffitz J.E., Johnston P., et al. Applicability of ultrasonic tissue characterization for longitudinal assessment and differentiation of calcification and fibrosis in cardiomyopathy. J Am Coll Cardiol 1984, 4:88-95.
61. Lee R.T., Grodzinsky A.J., Frank E.H., Kamm R.D., Schoen F.J. Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation 1991, 83:1764-1770.
62. Takiuchi S., Rakugi H., Honda K., Masuyama T., Hirata N., Ito H., et al. Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries. Circulation 2000, 102:766-770.
63. Wickline S.A., Thomas L.J., Miller J.G., Sobel B.E., Perez J.E. The dependence of myocardial integrated backscatter on contractile performance. Circulation 1985, 72:183-192.
64. Galetta F., Bernini G., Franzoni F., Tocchini L., Taurino C., Bardini M., et al. Preclinical cardiac involvement in phaeochromocytoma: a study with integrated backscatter. Clin Endocrinol (Oxf) 2008, 68(5):756-761.
65. Bernini G.P., Franzoni F., Galetta F., Moretti A., Taurino C., Bardini M., et al. Carotid vascular remodeling in patients with pheochromocytoma. J Clin Endocrinol Metab 2006, 91:1754-1760.
66. Bernini G., Galetta F., Franzoni F., Bardini M., Taurino C., Moretti A., et al. Normalization of catecholamine production following resection of phaeochromocytoma positively influences carotid vascular remodeling. Eur J Endocrinol 2008, 159(2):137-143.
67. Nozaki S., Demaria A.N., Helmer G.A., Hammond H.K. Detection of regional left ventricular dysfunction in early pacing-induced heart failure using ultrasonic integrated backscatter. Circulation 1995, 92:2675-2682.
68. Masuyama T., St Goar F.G., Tye T.L., Oppenheim G., Schnittger I., Popp L.R. Ultrasonic tissue characterization of human hypertrophied hearts in vivo with cardiac cycle-dependent variation in integrated backscatter. Circulation 1989, 80:925-934.
69. Madaras E.I., Perez J., Sobel B.E., Mottley J.G., Miller J.G. Anisotropy of the ultrasonic backscatter of myocardial tissue. II. Measurements in vivo. J Acoust Soc Am 1988, 83:762-769.
70. Hoyt R.M., Skorton D.J., Collins S.M., Melton H.E. Ultrasonic backscatter and collagen in normal ventricular myocardium. Circulation 1984, 69:775-782.
71. Mimbs J.W., O'Donnell M., Bawens D., Miller J.W., Sobel B.E. The dependence of ultrasonic attenuation and backscatter on collagen content in dog and rabbit hearts. Circ Res 1980, 47:49-58.
72. Picano E., Pelosi G., Marzilli M., Lattanzi F., Benassi A., Landini L., et al. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation 1990, 81:58-64.